Prelude Therapeutics Inc
PRLD
Revenue
0.00
0.000.00%
-Assets
224.29M
▼-22.82M▼-9.23%
3 Months ChangeLiabilities
42.02M
▲5.64M▲15.51%
3 Months ChangeFree Cash Flow
-32.08M
▼-1.14M▼-3.67%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-24
Form 8-K
ID: 0000950170-24-116853
2024-09-13
Form 8-K
ID: 0000950170-24-106362
2024-09-09
Form 8-K
ID: 0000950170-24-104575
2024-08-12
Form 10-Q
ID: 0000950170-24-095065
2024-08-12
Form 8-K
ID: 0000950170-24-095059
2024-06-18
Form 8-K
ID: 0000950170-24-074846
2024-06-12
Form 8-K
ID: 0000950170-24-072249
2024-05-07
Form 10-Q
ID: 0000950170-24-053940
2024-05-07
Form 8-K
ID: 0000950170-24-053931
2024-04-10
Form 8-K
ID: 0000950170-24-043347